Hot Deal Alert: Domino's® Pizza is 50% Off This Week!   •   Glaukos Achieves Pipeline Milestone with Enrollment Completion in Phase 3 Confirmatory Trial for Epioxa (Epi-on)   •   AGC Biologics Introduces AGCellerate, Offering Fast Timelines, Fixed Pricing and Guaranteed Product Quantity   •   Dr. Jen Ashton's "BETTER" Hits Newsstands Nationwide Today   •   Operation Homefront presents Cornerstone Award to Bob Deforge of Pratt & Whitney   •   U.S. Institute of Peace Opens Nominations for 2023 Women Building Peace Award   •   Baidu's 2022 ESG Report Highlights "Safe and Controllable" as Highest Principle of AI Ethics   •   Avalon Assisted Living at Hillsborough Partners with Quake Global to Improve Quality of Care.   •   ANDEXXA Phase IV Trial Stopped Early After Achieving Pre-specified Criteria on Hemostatic Efficacy Versus Usual Care   •   AlloVir Presents Positive Final Results From A Phase 2 Randomized, Placebo-Controlled Trial Evaluating Posoleucel Treatment of B   •   Builders FirstSource Raises Over $1.2 Million at its Swing for the Cure Golf Charity Event for The Leukemia & Lymphoma Socie   •   Bruker Launches timsTOF Ultra Mass Spectrometer with Transformative Sensitivity, 300 Hz PASEF MS/MS, and VistaScan™ for En   •   The Executive Leadership Council Announces the Appointment of Fabian Milburn as Chief Legal and Human Resources Officer   •   Seres Therapeutics and Nestlé Health Science Announce U.S. Commercial Availability of VOWST™, the First and Only FD   •   Cupshe Celebrates 8th Birthday with Exclusive Collection in Collaboration with Chanel Iman, Heather Rae El Moussa, and Brittany   •   New Web Addresses Pave the Way for LGBTQ+ Businesses to Thrive and Connect   •   PreOmics Introduces New ENRICH-iST Kits and Novel Workflow for Unbiased, Affordable Plasma and Serum Proteomics by LC-MS   •   Founders First Capital Partners Sponsors Women in Cloud to Foster Financial Opportunities for Women Tech Founders   •   Dr. Reddy’s Successfully Completes Phase I Study (IV Route) of DRL_TC, a Proposed Biosimilar of Tocilizumab   •   Bausch + Lomb Launches Bausch + Lomb INFUSE® Multifocal Silicone Hydrogel Contact Lenses in the United States